Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Eupraxia Pharmaceuticals Inc (TO: EPRX)

 
EPRX Technical Analysis
5
As on 4th Nov 2025 EPRX STOCK Price closed @ 7.75 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.14 & Strong Buy for SHORT-TERM with Stoploss of 3.68 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EPRXSTOCK Price

Open 8.49 Change Price %
High 8.49 1 Day -0.72 -8.50
Low 7.59 1 Week 0.10 1.31
Close 7.75 1 Month -1.12 -12.63
Volume 50349 1 Year 3.80 96.20
52 Week High 8.87 | 52 Week Low 3.15
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
BTO 5.61 -6.03%
UEX 0.50 16.28%
CNQ 44.18 -1.60%
TLO 0.40 11.11%
ENB 65.40 -0.18%
TRP 70.16 -0.24%
SJR-B 40.48 0.02%
MFC 46.28 -0.30%
CXB 2.99 -0.33%
 
TO Canada Top Gainers Stocks
ONC 16.90 1090.14%
ONC 16.90 1090.14%
CUB 0.21 950.00%
CUB 0.21 950.00%
AOI 13.38 611.70%
AOI 13.38 611.70%
GGA 0.03 50.00%
MIN 0.20 42.86%
MIN 0.20 42.86%
MIN 0.20 42.86%
 
TO Canada Top Losers Stocks
MOZ 0.16 -80.25%
MOZ 0.16 -80.25%
BNG 0.01 -50.00%
APLI 0.02 -33.33%
APLI 0.02 -33.33%
CJR-B 0.04 -33.33%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
SMC 0.02 -33.33%
 
 
EPRX
Daily Charts		 EPRX
Intraday Charts		 Whats New @
Bazaartrend		 EPRX
Free Analysis
 
EPRX Important Levels Intraday
RESISTANCE9.48
RESISTANCE8.93
RESISTANCE8.58
RESISTANCE8.24
SUPPORT7.26
SUPPORT6.92
SUPPORT6.57
SUPPORT6.02
 
EPRX Forecast November 2025
Share
4th UP Forecast9
3rd UP Forecast8.6
2nd UP Forecast8.35
1st UP Forecast8.1
1st DOWN Forecast7.4
2nd DOWN Forecast7.15
3rd DOWN Forecast6.9
4th DOWN Forecast6.5
 
EPRX Weekly Forecast
4th UP Forecast8.21
3rd UP Forecast8.06
2nd UP Forecast7.97
1st UP Forecast7.88
1st DOWN Forecast7.62
2nd DOWN Forecast7.53
3rd DOWN Forecast7.44
4th DOWN Forecast7.29
 
EPRX Forecast2025
4th UP Forecast20.62
3rd UP Forecast16.49
2nd UP Forecast13.94
1st UP Forecast11.39
1st DOWN Forecast4.11
2nd DOWN Forecast1.56
3rd DOWN Forecast-0.99
4th DOWN Forecast-5.12
 
 
EPRX Other Details
Segment EQ
Market Capital 30621592.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EPRX Address
EPRX
 
EPRX Latest News
 
Your Comments and Response on Eupraxia Pharmaceuticals Inc
 
EPRX Business Profile
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. Address: 2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service